These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 15356218

  • 1. Effect of dextrometorphan and dextrorphan on nicotine and neuronal nicotinic receptors: in vitro and in vivo selectivity.
    Damaj MI, Flood P, Ho KK, May EL, Martin BR.
    J Pharmacol Exp Ther; 2005 Feb; 312(2):780-5. PubMed ID: 15356218
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological characterization of nicotine's interaction with cocaine and cocaine analogs.
    Damaj MI, Slemmer JE, Carroll FI, Martin BR.
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1229-36. PubMed ID: 10336510
    [Abstract] [Full Text] [Related]

  • 3. Bupropion is a nicotinic antagonist.
    Slemmer JE, Martin BR, Damaj MI.
    J Pharmacol Exp Ther; 2000 Oct; 295(1):321-7. PubMed ID: 10991997
    [Abstract] [Full Text] [Related]

  • 4. Influence of gender and sex hormones on nicotine acute pharmacological effects in mice.
    Damaj MI.
    J Pharmacol Exp Ther; 2001 Jan; 296(1):132-40. PubMed ID: 11123373
    [Abstract] [Full Text] [Related]

  • 5. Analysis of mecamylamine stereoisomers on human nicotinic receptor subtypes.
    Papke RL, Sanberg PR, Shytle RD.
    J Pharmacol Exp Ther; 2001 May; 297(2):646-56. PubMed ID: 11303054
    [Abstract] [Full Text] [Related]

  • 6. Dextromethorphan and its metabolite dextrorphan block alpha3beta4 neuronal nicotinic receptors.
    Hernandez SC, Bertolino M, Xiao Y, Pringle KE, Caruso FS, Kellar KJ.
    J Pharmacol Exp Ther; 2000 Jun; 293(3):962-7. PubMed ID: 10869398
    [Abstract] [Full Text] [Related]

  • 7. Comparative effects of dextromethorphan and dextrorphan on nicotine discrimination in rats.
    Wright MJ, Vann RE, Gamage TF, Damaj MI, Wiley JL.
    Pharmacol Biochem Behav; 2006 Nov; 85(3):507-13. PubMed ID: 17112574
    [Abstract] [Full Text] [Related]

  • 8. Antinociceptive responses to nicotinic acetylcholine receptor ligands after systemic and intrathecal administration in mice.
    Damaj MI, Fei-Yin M, Dukat M, Glassco W, Glennon RA, Martin BR.
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1058-65. PubMed ID: 9495867
    [Abstract] [Full Text] [Related]

  • 9. Nicotinic receptor agonists and antagonists increase sAPPalpha secretion and decrease Abeta levels in vitro.
    Mousavi M, Hellström-Lindahl E.
    Neurochem Int; 2009 Mar; 54(3-4):237-44. PubMed ID: 19111588
    [Abstract] [Full Text] [Related]

  • 10. Nicotinic receptor-mediated enhancement of long-term potentiation involves activation of metabotropic glutamate receptors and ryanodine-sensitive calcium stores in the dentate gyrus.
    Welsby P, Rowan M, Anwyl R.
    Eur J Neurosci; 2006 Dec; 24(11):3109-18. PubMed ID: 17156372
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors h alpha 2 beta 2, h alpha 2 beta 4, h alpha 3 beta 2, h alpha 3 beta 4, h alpha 4 beta 2, h alpha 4 beta 4 and h alpha 7 expressed in Xenopus oocytes.
    Chavez-Noriega LE, Crona JH, Washburn MS, Urrutia A, Elliott KJ, Johnson EC.
    J Pharmacol Exp Ther; 1997 Jan; 280(1):346-56. PubMed ID: 8996215
    [Abstract] [Full Text] [Related]

  • 12. Pharmacological characterization of nicotine-induced seizures in mice.
    Damaj MI, Glassco W, Dukat M, Martin BR.
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1284-91. PubMed ID: 10565853
    [Abstract] [Full Text] [Related]

  • 13. Involvement of calcium and L-type channels in nicotine-induced antinociception.
    Damaj MI, Welch SP, Martin BR.
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1330-8. PubMed ID: 7690401
    [Abstract] [Full Text] [Related]

  • 14. Involvement of spinal Met-enkephalin in nicotine-induced antinociception in mice.
    Kiguchi N, Maeda T, Tsuruga M, Yamamoto A, Yamamoto C, Ozaki M, Kishioka S.
    Brain Res; 2008 Jan 16; 1189():70-7. PubMed ID: 18048009
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Neurochemical and behavioral effects of bupropion and mecamylamine in the presence of nicotine.
    Vann RE, Rosecrans JA, James JR, Philibin SD, Robinson SE.
    Brain Res; 2006 Oct 30; 1117(1):18-24. PubMed ID: 16949560
    [Abstract] [Full Text] [Related]

  • 17. Chronic nicotine and dizocilpine effects on regionally specific nicotinic and NMDA glutamate receptor binding.
    Levin ED, Tizabi Y, Rezvani AH, Caldwell DP, Petro A, Getachew B.
    Brain Res; 2005 Apr 18; 1041(2):132-42. PubMed ID: 15829222
    [Abstract] [Full Text] [Related]

  • 18. Untranslated region-dependent exclusive expression of high-sensitivity subforms of alpha4beta2 and alpha3beta2 nicotinic acetylcholine receptors.
    Briggs CA, Gubbins EJ, Marks MJ, Putman CB, Thimmapaya R, Meyer MD, Surowy CS.
    Mol Pharmacol; 2006 Jul 18; 70(1):227-40. PubMed ID: 16569710
    [Abstract] [Full Text] [Related]

  • 19. Antinociceptive and pharmacological effects of metanicotine, a selective nicotinic agonist.
    Damaj MI, Glassco W, Aceto MD, Martin BR.
    J Pharmacol Exp Ther; 1999 Oct 18; 291(1):390-8. PubMed ID: 10490929
    [Abstract] [Full Text] [Related]

  • 20. Kynurenic acid does not protect against nicotine-induced seizures in mice.
    Kiś J, Czuczwar M, Zielińska E, Bojar I, Czuczwar SJ, Turski WA.
    Pol J Pharmacol; 2000 Oct 18; 52(6):477-80. PubMed ID: 11334243
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.